UF researcher launches novel immunotherapy trial for pediatric cancers
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
An article in The Economist highlights how cancer vaccines are showing promise.
An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.
The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.